Financials

  • Market Capitalization 12.33 B
  • Employee 915
  • Founded 2011
  • CEO Paul A. Friedman
  • Website www.madrigalpharma.com
  • Headquarter Delaware, United States
  • FIGI BBG000QS6NV8
  • Industry Biyoteknoloji
Toplam gelir
Net kar
Temel hisse başına kazanç (Temel EPS)
Toplam borç
Serbest nakit akışı
Nakit ve eşdeğerleri
Fiyat/kazanç oranı
-35.68
Fiyat/satışlar oranı
10.67

Related tickers

#AdFiyat24s %7g %1A %1Y %Piyasa DeğeriSon 7 Gün
759
EXEL
Exelixis, Inc. - Common Stock
54.45 USD-1.47%+1.04%-2.35%+39.47%13.49 B USD
799
BMRN
BioMarin Pharmaceutical Inc. - Common Stock
64.67 USD-0.95%-2.85%+7.11%+10.74%12.52 B USD
810
CORT
Corcept Therapeutics Incorporated - Common Stock
113.88 USD-2.61%-5.54%-3.57%+55.21%12.31 B USD
823
ARWR
Arrowhead Pharmaceuticals, Inc. - Common Stock
84.91 USD-4.15%-2.14%-2.32%+117.16%11.99 B USD

Haberler